Synthesis and antitumor activity of bis(arylsulfonyl)dihydroimidazolinone derivatives

Bioorganic & Medicinal Chemistry Letters
2020.0

Abstract

A series of novel bis(arylsulfonyl)dihydroimidazolinones with different aryl substitution patterns were readily synthesized and evaluated for their antitumor activities. Some of the newly synthesized compounds exhibited cytotoxicity at micromolar range against multiple cancer cell lines, including A549, HepG2, HuCCA-1, and MOLT-3. The most potent analogue contained pentafluorobenzenesulfonyl groups, which could be chemically elaborated to serve as a potential pharmacophore.

Knowledge Graph

Similar Paper

Synthesis and antitumor activity of bis(arylsulfonyl)dihydroimidazolinone derivatives
Bioorganic & Medicinal Chemistry Letters 2020.0
Structure–activity relationship study of arylsulfonylimidazolidinones as anticancer agents
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis and antitumor activity of 4-phenyl-1-arylsulfonyl imidazolidinones
Bioorganic & Medicinal Chemistry Letters 1998.0
Synthesis and evaluation of 2-[2-(phenylthiomethyl)-1H-benzo[d] imidazol-1-yl)acetohydrazide derivatives as antitumor agents
Bioorganic & Medicinal Chemistry Letters 2012.0
Synthesis of some p-toluenesulfonyl-hydrazinothiazoles and hydrazino-bis-thiazoles and their anticancer activity
European Journal of Medicinal Chemistry 2010.0
Structure–activity relationship studies of novel arylsulfonylimidazolidinones for their anticancer activity
European Journal of Medicinal Chemistry 2011.0
Synthesis and cytotoxic activity of novel hexahydropyrrolo[2,3- b ]indole imidazolium salts
Bioorganic & Medicinal Chemistry Letters 2016.0
Synthesis and cytotoxic activities of novel hybrid 2-phenyl-3-alkylbenzofuran and imidazole/triazole compounds
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and cytotoxic activity of N-(2-pyridylsulfenyl)urea derivatives. A new class of potential antineoplastic agents
Bioorganic & Medicinal Chemistry Letters 1999.0
Synthesis, single crystal and antitumor activities of benzimidazole–quinazoline hybrids
Bioorganic & Medicinal Chemistry Letters 2013.0